Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ciclopirox reprograms effector responses and modulates Notch1 activation in activated human T cells.

iScience·2026
Same author

Novel <i>N</i>-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance.

Cancer drug resistance (Alhambra, Calif.)·2026
Same author

Continuous flow synthesis of MOF/nanocarbon composites.

Nanoscale·2026
Same author

Isoselenocyanates: Synthesis and Their Use for Preparing Selenium-Based Heterocycles.

Synthesis·2026
Same author

Low-cost, tape-sealed, PDMS-molded devices using 3D printing for cell adhesion under flow.

Analytical and bioanalytical chemistry·2026
Same author

Differentiating between BK activation and potentiation by vanzacaftor enantiomers.

American journal of physiology. Cell physiology·2026

Related Experiment Video

Updated: Jun 4, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomes using triggered release.

Matthew T Basel1, Tej B Shrestha, Deryl L Troyer

  • 1Department of Chemistry, 213 CBC Building, Kansas State University, Manhattan, KS 66506, USA. mbasel@vet.ksu.edu

ACS Nano
|February 15, 2011
PubMed
Summary

This study introduces protease-triggered, caged liposomes for enhanced drug delivery. These novel liposomes offer improved tumor targeting, faster drug release, and reduced leakage, overcoming limitations of traditional liposome formulations.

More Related Videos

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation
12:00

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation
12:00

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Drug Delivery Systems

Background:

  • Liposomes are established drug carriers utilizing the enhanced permeation and retention (EPR) effect for tumor targeting.
  • Limitations include imperfect specificity, slow drug release, and premature leakage.
  • Cancer-associated proteases (CAPs) offer a promising avenue for active tumor targeting.

Purpose of the Study:

  • To develop a novel liposome system combining EPR targeting with CAP sensitivity for improved specificity and drug release.
  • To engineer protease-triggered, caged liposomes with enhanced stability and controlled release kinetics.
  • To evaluate the efficacy of these liposomes in targeting and drug release in a tumor microenvironment.

Main Methods:

  • Synthesized cholesterol-anchored graft copolymers with urokinase plasminogen activator (uPA) peptide sequences and poly(acrylic acid).
  • Incorporated these copolymers into liposomes prepared at high osmolarities, creating an unstable core.
  • Stabilized liposomes with a cross-linked polymer shell forming protease-triggered, caged liposomes.

Main Results:

  • Protease-triggered, caged liposomes demonstrated significant resistance to osmotic swelling and content leakage.
  • These liposomes exhibited substantial differential release of contents specifically in the presence of uPA.
  • Bare liposomes showed no differential release in the presence of uPA, confirming protease sensitivity.

Conclusions:

  • Developed a protease-sensitive liposome system with fast release kinetics for targeted cancer therapy.
  • This novel system enhances specificity, reduces leakage, and improves drug release at the tumor site.
  • Offers a promising platform for more effective and targeted cancer drug delivery strategies.